Key Points
- Proto Labs CFO Daniel Schumacher sold 4,900 shares at an average price of $85.21, totaling $417,529. The Rule 10b5-1 transaction reduced his direct holdings by 10.91% to 40,019 shares.
- Proto Labs reported quarterly EPS of $0.60, exceeding the $0.53 consensus estimate, while revenue rose 10.5% year over year to $149.34 million. The company issued third-quarter 2026 EPS guidance of $0.56–$0.64.
- Analyst sentiment remains favorable, with the stock carrying an average “Buy” rating and an average price target of $89.00; institutional investors own 84.54% of outstanding shares.
Proto Labs, Inc. (NYSE:PRLB - Get Free Report) CFO Daniel Schumacher sold 4,900 shares of the company's stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $85.21, for a total value of $417,529.00. Following the completion of the transaction, the chief financial officer directly owned 40,019 shares of the company's stock, valued at approximately $3,410,018.99. This trade represents a 10.91% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Daniel Schumacher also recently made the following trade(s):
- On Wednesday, September 16th, Daniel Schumacher sold 100 shares of Proto Labs stock. The shares were sold at an average price of $85.00, for a total value of $8,500.00.
Proto Labs Trading Up 1.2%
NYSE PRLB opened at $87.47 on Friday. The stock's 50 day moving average is $81.41 and its 200 day moving average is $72.66. Proto Labs, Inc. has a 12 month low of $45.10 and a 12 month high of $93.00. The stock has a market cap of $2.09 billion, a PE ratio of 69.98 and a beta of 1.42.
Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.07. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The business had revenue of $149.34 million during the quarter, compared to the consensus estimate of $144.53 million. During the same period in the prior year, the company posted $0.41 EPS. The firm's revenue for the quarter was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, analysts forecast that Proto Labs, Inc. will post 1.46 EPS for the current fiscal year.
Analysts Set New Price Targets
Several research firms recently weighed in on PRLB. Weiss Ratings raised shares of Proto Labs from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, September 3rd. Benchmark boosted their price target on shares of Proto Labs from $70.00 to $91.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Zacks Research raised shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 6th. Wall Street Zen lowered Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. Finally, Needham & Company LLC upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price on the stock in a research report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $89.00.
Get Our Latest Research Report on PRLB
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the business. Engineers Gate Manager LP lifted its position in Proto Labs by 84.7% during the second quarter. Engineers Gate Manager LP now owns 26,780 shares of the industrial products company's stock valued at $2,183,000 after purchasing an additional 12,280 shares during the last quarter. Corient Private Wealth LP grew its stake in shares of Proto Labs by 16.1% in the 2nd quarter. Corient Private Wealth LP now owns 12,427 shares of the industrial products company's stock worth $1,013,000 after buying an additional 1,723 shares in the last quarter. Angeles Wealth Management LLC increased its holdings in shares of Proto Labs by 12.4% in the 2nd quarter. Angeles Wealth Management LLC now owns 5,045 shares of the industrial products company's stock worth $411,000 after buying an additional 555 shares during the last quarter. Turner Financial Group Inc. bought a new stake in shares of Proto Labs in the 2nd quarter worth about $395,000. Finally, Susquehanna Fundamental Investments LLC raised its position in shares of Proto Labs by 227.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 33,760 shares of the industrial products company's stock valued at $2,752,000 after buying an additional 23,435 shares in the last quarter. 84.54% of the stock is owned by hedge funds and other institutional investors.
Proto Labs Company Profile
(
Get Free Report)
Proto Labs, Inc (NYSE: PRLB), doing business as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. Its platform enables engineers and product developers to upload three-dimensional computer-aided design files, receive automated design analyses and quotes, and order custom parts through a streamlined online process.
The company offers computer numerical control machining, injection molding, 3D printing and sheet-metal fabrication.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
